Initial experience with a group presentation of study results to research participants
Andrew L Avins, Stephen Bent, Amy Padula, Suzanne Staccone, Evelyn Badua, Harley Goldberg, Andrew L Avins, Stephen Bent, Amy Padula, Suzanne Staccone, Evelyn Badua, Harley Goldberg
Abstract
Background: Despite ethical imperatives, informing research participants about the results of the studies in which they take part is not often performed. This is due, in part, to the costs and burdens of communicating with each participant after publication of the results.
Methods: Following the closeout and publication of a randomized clinical trial of saw palmetto for treatment of symptoms of benign prostatic hyperplasia, patients were invited back to the research center to participate in a group presentation of the study results.
Results: Approximately 10% of participants attended one of two presentation sessions. Reaction to the experience of the group presentation was very positive among the attendees.
Conclusion: A group presentation to research participants is an efficient method of communicating study results to those who desire to be informed and was highly valued by those who attended. Prospectively planning for such presentations and greater scheduling flexibility may result in higher attendance rates.
Trial registration number: Clinicaltrials.gov #NCT00037154.
References
- Di Blasi Z, Crawford F, Bradley C, Kleijnen J. Reactions to treatment debriefing among the participants of a placebo controlled trial. BMC Health Serv Res. 2005;5:30. doi: 10.1186/1472-6963-5-30.
- Dixon-Woods M, Jackson C, Windridge KC, Kenyon S. Receiving a summary of the results of a trial: qualitative study of participants' views. Bmj. 2006;332:206–210. doi: 10.1136/bmj.38675.677963.3A.
- Marshall S. How to get patients consent to enter clinical trials. Participants should be given feedback about the trial. Bmj. 1996;312:186.
- Partridge AH, Burstein HJ, Gelman RS, Marcom PK, Winer EP. Do patients participating in clinical trials want to know study results? J Natl Cancer Inst. 2003;95:491–492.
- Partridge AH, Winer EP. Informing clinical trial participants about study results. Jama. 2002;288:363–365. doi: 10.1001/jama.288.3.363.
- Snowdon C, Garcia J, Elbourne D. Reactions of participants to the results of a randomised controlled trial: exploratory study. Bmj. 1998;317:21–26.
- Partridge AH, Hackett N, Blood E, Gelman R, Joffe S, Bauer-Wu S, Knudsen K, Emmons K, Collyar D, Schilsky RL, Winer EP. Oncology physician and nurse practices and attitudes regarding offering clinical trial results to study participants. J Natl Cancer Inst. 2004;96:629–632.
- Rigby H, Fernandez CV. Providing research results to study participants: support versus practice of researchers presenting at the American Society of Hematology annual meeting. Blood. 2005;106:1199–1202. doi: 10.1182/blood-2005-02-0556.
- MacNeil SD, Fernandez CV. Offering results to research participants. Bmj. 2006;332:188–189. doi: 10.1136/bmj.332.7535.188.
- Fernandez CV, Skedgel C, Weijer C. Considerations and costs of disclosing study findings to research participants. Cmaj. 2004;170:1417–1419.
- Goodare H, Smith R. The rights of patients in research. Bmj. 1995;310:1277–1278.
- Shalowitz DI, Miller FG. Disclosing individual results of clinical research: implications of respect for participants. Jama. 2005;294:737–740. doi: 10.1001/jama.294.6.737.
- Fernandez CV, Kodish E, Shurin S, Weijer C. Offering to return results to research participants: attitudes and needs of principal investigators in the Children's Oncology Group. J Pediatr Hematol Oncol. 2003;25:704–708. doi: 10.1097/00043426-200309000-00006.
- Bent S, Kane C, Shinohara K, Neuhaus J, Hudes ES, Goldberg H, Avins AL. Saw palmetto for benign prostatic hyperplasia. N Engl J Med. 2006;354:557–566. doi: 10.1056/NEJMoa053085.
- DiPaola RS, Morton RA. Proven and unproven therapy for benign prostatic hyperplasia. N Engl J Med. 2006;354:632–634. doi: 10.1056/NEJMe058301.
Source: PubMed